Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer

Author(s): Lyumkis D, Julien JP, de Val N, Cupo A, Potter CS, et al.

Abstract

The HIV-1 envelope glycoprotein (Env) trimer contains the receptor binding sites and membrane fusion machinery that introduce the viral genome into the host cell. As the only target for broadly neutralizing antibodies (bnAbs), Env is a focus for rational vaccine design. We present a cryo–electron microscopy reconstruction and structural model of a cleaved, soluble Env trimer (termed BG505 SOSIP.664 gp140) in complex with a CD4 binding site (CD4bs) bnAb, PGV04, at 5.8 angstrom resolution. The structure reveals the spatial arrangement of Env components, including the V1/V2, V3, HR1, and HR2 domains, as well as shielding glycans. The structure also provides insights into trimer assembly, gp120-gp41 interactions, and the CD4bs epitope cluster for bnAbs, which covers a more extensive area and defines a more complex site of vulnerability than previously described.

Similar Articles

Trial, error and breakthrough: A review of HIV vaccine development

Author(s): Barry SM, Mena Lora AJ, Novak RM

Cell responses to HIV-1 infection and vaccination: pathways to preventing infection

Author(s): Haynes BF, Moody MA, Liao HX, Verkoczy L, Tomaras GD

The antigenic structure of the HIV gp120 envelope glycoprotein

Author(s): Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, et al.

Crystal structure of a soluble cleaved HIV-1 envelope trimer

Author(s): Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, et al.

Gene therapy as a vaccine for HIV-1

Author(s): Berkhout B, Sanders RW

Antibody gene transfer for HIV immunoprophylaxis

Author(s): Balazs AB, West AP

Rapamycin-regulated control of antiangiogenic tumor therapy following raav-mediated gene transfer

Author(s): Nguyen M, Huan-Tu G, Gonzalez-Edick M, Rivera VM, Clackson T, et al.

Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation

Author(s): Hütter G, Nowak D, Mossner M, Ganepola S, Müßig A, et al.

Novel targets for antiretroviral therapy

Author(s): Dau B, Holodniy M.

Study record detail USA

Author(s): US National library of Medicine

Study record detail USA

Author(s): US National library of Medicine

Study record detail USA

Author(s): US National library of Medicine

Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env

Author(s): Scharf L, Wang H, Gao H, Chen S, McDowall AW, et al.